2.57
-0.09(-3.38%)
Currency In USD
| Previous Close | 2.66 |
| Open | 2.66 |
| Day High | 2.72 |
| Day Low | 2.56 |
| 52-Week High | 5.31 |
| 52-Week Low | 1.84 |
| Volume | 471,068 |
| Average Volume | 954,677 |
| Market Cap | 131.34M |
| PE | -1.74 |
| EPS | -1.48 |
| Moving Average 50 Days | 2.77 |
| Moving Average 200 Days | 3.19 |
| Change | -0.09 |
If you invested $1000 in Achieve Life Sciences, Inc. (ACHV) 10 years ago, it would be worth $0.47 as of August 20, 2025 at a share price of $2.57. Whereas If you bought $1000 worth of Achieve Life Sciences, Inc. (ACHV) shares 5 years ago, it would be worth $292.05 as of August 20, 2025 at a share price of $2.57.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference
GlobeNewswire Inc.
Jul 29, 2025 12:30 PM GMT
SEATTLE and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treat
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025
GlobeNewswire Inc.
Jul 24, 2025 12:30 PM GMT
SEATTLE and VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treat
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities
GlobeNewswire Inc.
Jun 30, 2025 11:52 PM GMT
SEATTLE and VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treat